The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clonal hematopoiesis association with cardiac function and mortality in patients with solid tumors.
 
Jessica A. Regan
No Relationships to Disclose
 
Michelle Green
Employment - N-of-One
Research Funding - Bayer (Inst)
 
Chester Kao
No Relationships to Disclose
 
Eric Powers
No Relationships to Disclose
 
Jadee Neff
Honoraria - EUSA Pharma
Consulting or Advisory Role - EUSA Pharma; Spring Discovery
Speakers' Bureau - EUSA Pharma
 
John H. Strickler
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Chengdu Kanghong Biotech; Mereo Biopharma; Natera (Inst); Pfizer; Seagen (Inst); Viatris
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Curegenix (Inst); Daiichi Sankyo/Lilly; Exelixis (Inst); Leap Therapeutics (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Seagen
 
Matthew Stuart McKinney
Honoraria - Kite/Gilead
Consulting or Advisory Role - BTG; Celgene; Epizyme; Genentech; Kite/Gilead; Molecular Templates; Pharmacyclics; Seagen; Takeda; Verastem
Speakers' Bureau - Kite/Gilead
Research Funding - Atara Biotherapeutics (Inst); BeiGene (Inst); Celgene (Inst); De Novo Pharmaceuticals (Inst); Genentech (Inst); Incyte (Inst); Molecular Templates (Inst); Nordic Nanovector (Inst); Novartis (Inst); Pharmacyclics (Inst); Unum Therapeutics (Inst)
 
Svati H. Shah
Leadership - BioSense Webster (I)
Stock and Other Ownership Interests - NewPace (I)
Consulting or Advisory Role - BioSense Webster (I); Cardiva Medical (I)
Speakers' Bureau - BioSense Webster (I)
Research Funding - AstraZeneca; Lilly; Project Baseline
Patents, Royalties, Other Intellectual Property - Duke University - PI on unlicensed patent for metabolomics finding; Royalties from Mc-Graw-Hill Publishing (I)
Travel, Accommodations, Expenses - Olink Bioscience
Other Relationship - American Academic Health System
 
Tian Zhang
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
Honoraria - Exelixis; Genentech/Roche; MJH Life Sciences; Pacific Genuity
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Calithera Biosciences; Dendreon; Exelixis; Foundation Medicine; Genentech/Roche; Janssen; Merck; Pfizer; Pharmacyclics; Sanofi; Seagen
Speakers' Bureau - Exelixis; Genentech/Roche; Genomic Health; Sanofi/Aventis
Research Funding - Acerta Pharma (Inst); Astellas Pharma; Janssen (Inst); Merck (Inst); Merrimack (Inst); Mirati Therapeutics (Inst); Novartis (Inst); OmniSeq (Inst); Personal Genome Diagnostics (Inst); Pfizer (Inst); Regeneron (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; AstraZeneca; Genomic Health